Message from the Chair – This New Year brings great anticipation for progress in the treatment of melanoma and skin cancers, like cutaneous squamous cell carcinoma (cSCC). We have been anxiously awaiting provincial listings for adjuvant therapies for melanoma – in particular the adjuvant (for stage III fully resected patients), targeted therapy combination of Dabrafenib and Trametinib, and the adjuvant immunotherapies – Pembrolizumab and Nivolumab.
On Tuesday, June 13, 2017, I was diagnosed with uveal melanoma. This was my lucky day. For over 10 months, I had been experiencing huge flashes of light in the periphery of my right eye, along with rapidly declining vision,
Host an Event In Support Of Melanoma. From hockey and golf tournaments to birthday and dinner parties, there are many events that allow you to gather with friends and family, raise money for a noble cause, and rally around someone going through their cancer journey.
Sign up to receive the latest news from Melanoma Network of Canada
